Abstract:The majority of patients with non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations inevitably progress in stage despite an initial substantial and rapid response to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). Previous research indicates that hypoxia may be associated with resistance to EGFR-TKIs in EGFR mutation-positive NSCLC. Therefore, the present study regulated the activity of hypoxia-inducible factor-1 (HIF-1) signaling pathway to observe if it is able to alter the sensitivity of lung cancer cells to gefitinib. The present study selected 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) and dimethyloxalylglycine (DMOG) as a HIF-1 signaling pathway inhibitor and activator, respectively, on HCC827 cells. Cells were incubated with different treatments for different durations: A blank control, DMOG, gefitinib, or DMOG and gefitinib combined, for 36 and 48 h; and then a blank control, YC-1, gefitinib, or YC-1 and gefitinib combined, for 16 and 28 h. A western blot analysis assay was performed to evaluate the protein expression levels of HIF-1α and phosphorylated hepatocyte growth factor receptor (p-MET), an MTT assay was used to determine cell proliferation, a colony formation assay was used to investigate the colony-forming ability and a wound healing assay was used to test the cell migration ability. Additionally, Pearson's correlation analysis was used to evaluate the correlation between p-Met and HIF-1α expression levels. Finally, it was identified that gefitinib and DMOG combined notably improve the growth and cell migration ability of HCC827 cells, compared with gefitinib alone. When gefitinib and YC-1 were combined, the inhibiting effect on the growth and cell migration ability of HCC827 cells was substantially enhanced, compared with the control cells. Pearson's correlation analysis revealed that the p-Met expression level had a strong positive correlation with HIF-1α expression levels. Thus, it was concluded that the HIF-1 signaling pathway influences the sensitivity of HCC827 cells to gefitinib. The positive correlation between p-Met and HIF-1α expression levels may be the underlying mechanism of the HIF-1 signaling pathway influencing the sensitivity of HCC827 cells to gefitinib.

[Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells].

The mechanism of expression of hpoxic induced factor 1α in renal clear carcinoma 786-O cells and its significance

Hypoxia Inducible Factor-1Α Gene Silencing Aggravates Growth Inhibition and Necrosis of Human Proximal Renal Tubular Epithelial Cell under Hypoxia

Oxia Inducible Factor 1α and Hypoxia Inducible Factor 2α Distinct and Functionally Overlapping Roles in R L Squamous Cell Carcinoma

Hypoxia-inducible Factor-1 Signaling Pathway Influences the Sensitivity of HCC827 Cells to Gefitinib.

Expression and significance of HIF-1α mRNA and HIF-2α mRNA in human renal clear cell cancer

[Expression of Hypoxia-Inducible Factor-1-alpha, Hypoxia-Inducible Factor-2Alpha and Vascular Endothelial Growth Factor in Sporadic Clear Cell Renal Cell Renal Cell Carcinoma and Their Significance in the Pathogenesis Thereof].

Effect of HIF-1αby RNAi on Radiosensitivity in Esophageal Squamous Carcinoma Cell Line Eca109 under Hypoxia

Factor Inhibiting HIF1α (FIH-1) Functions As a Tumor Suppressor in Human Colorectal Cancer by Repressing HIF1α Pathway.

Effects of Insulin-1Ike Growth Factor 1 and Its Receptor on Proliferation of Ovarian Cancer Cells

Silencing of HIF-1α Suppresses Tumorigenicity of Renal Cell Carcinoma Through Induction of Apoptosis

Role of Hypoxia Stimulated Expression of Connective Tissue Growth Factor in Renal Interstitial Fibrosis

Hypoxia-inducible factor 1α (HIF-1α) correlated with tumor growth and apoptosis in ovarian cancer

Progress of Hypoxia-inducing Factor 1

Expression and significance of HIF-1α and HIF-2α in human renal clear cell cancer

HIF-1α Expression Correlates with Cellular Apoptosis, Angiogenesis and Clinical Prognosis in Rectal Carcinoma

Effect of hypoxia inducible factor-1α gene silencing on cell growth, invasion and apoptosis of BxPC-3 cells

The Impact of Hypoxia-Inducible Transcription Factor-1Α on Ovarian Carcinoma Cell

Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on Kidney Renal Clear Cell Carcinoma

Suppression of Renal Cell Carcinoma Growth in Vivo by Forced Expression of Vascular Endothelial Growth Inhibitor.

Suppression of Insulin-Like Growth Factor-1 Receptor by RNA Interference Inhibits Cell Growth in Vitro and Induces Chemosensitization of HO8910PM Cell to Cisplatin